NCT04333823View on ClinicalTrials.gov

Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 11, 2020

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Dapagliflozin 5mg

Dapagliflozin tablet

DRUG

Placebo

Sugar pill manufactured to mimic Dapagliflozin 5mg tablet

Trial Locations (3)

80045

Children's Hospital Colorado Anschutz Medical Campus, Aurora

N6A5W9

London Health Sciences Centre Children's Hospital, London

M5G 1X8

The Hospital for Sick Children, Toronto

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

The Hospital for Sick Children

OTHER